HAEMATO AG | Cash Flow

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
8,991.20
6,866.30
5,539.60
11,036.70
6,982.70
6,276.50
Depreciation, Depletion & Amortization
1,813.20
2,055.80
1,799.80
1,805.30
1,854.30
1,456.10
Other Funds
7,514.70
8,593.00
3,173.40
6,464.20
1,797.10
90.40
Funds from Operations
3,289.70
329.10
4,166.00
6,226.50
6,808.00
7,640.10
Changes in Working Capital
7,113.40
6,232.30
2,767.10
5,345.00
16,486.90
7,821.50
Net Operating Cash Flow
3,823.80
6,561.40
1,399.00
11,571.50
9,678.90
181.40
Capital Expenditures
27,282.10
5,645.40
850.00
725.40
1,464.00
Sale of Fixed Assets & Businesses
30,853.60
3,812.80
54.60
-
-
Purchase/Sale of Investments
-
-
342.20
146.80
6,268.10
Net Investing Cash Flow
2,454.70
1,832.60
453.20
623.60
4,804.10
Cash Dividends Paid - Total
3,407.00
6,233.70
6,233.70
5,300.90
6,594.00
Issuance/Reduction of Debt, Net
427.50
182.90
5,313.30
1,694.80
700.50
Net Financing Cash Flow
2,065.20
5,620.80
920.40
3,606.10
1,553.40
Net Change in Cash
4,213.20
891.90
25.40
7,341.80
3,321.40
Free Cash Flow
31,105.90
916.00
912.60
11,450.40
9,869.90
Deferred Taxes & Investment Tax Credit
-
-
-
151.40
231.90
182.80
Net Assets from Acquisitions
-
-
-
45.00
-
Change in Capital Stock
5,044.80
430.00
-
-
7,446.80
Other Uses
6,026.20
-
-
-
-

About HAEMATO

View Profile
Address
Lilienthalstraße 5c
Schönefeld Brandenburg 12529
Germany
Employees -
Website http://haemato.de
Updated 07/08/2019
Haemato AG engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes therapies for cancer, HIV, rheumatology, and other chronic diseases. It also consists of products for the privately financed market for aesthetic treatments.